How Cost-Effective Are New Cancer Drugs in the U.S.?

Expert Review of Pharmacoeconomics and Outcomes Research - United Kingdom
doi 10.1080/14737167.2020.1709965
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited